Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Dividends Paid - Common (2023 - 2024)

Historic Dividends Paid - Common for BioNexus Gene Lab (BGLC) over the last 2 years, with Q3 2024 value amounting to $2429.0.

  • BioNexus Gene Lab's Dividends Paid - Common fell 592.56% to $2429.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $9057.0, marking a year-over-year change of. This contributed to the annual value of $8877.0 for FY2023, which is 1389.53% up from last year.
  • BioNexus Gene Lab's Dividends Paid - Common amounted to $2429.0 in Q3 2024, which was down 592.56% from $1834.0 recorded in Q2 2024.
  • BioNexus Gene Lab's Dividends Paid - Common's 5-year high stood at $2711.0 during Q1 2024, with a 5-year trough of $1779.0 in Q1 2023.